Mathieu Bourdenx

Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade

Alzheimer’s Disease and Parkinson’s Disease: A Review of Current Treatment Adopting a Nanotechnology Approach

A pupal transcriptomic screen identifies Ral as a target of store-operated calcium entry in Drosophila neurons

Enhancing extracellular vesicle cargo loading and functional delivery by engineering protein-lipid interactions

Mechanisms, regulation and functions of the unfolded protein response

Chaperone-mediated autophagy sustains haematopoietic stem-cell function

Hallmarks of aging: An expanding universe

Understanding Dopaminergic Cell Death Pathways in Parkinson Disease

Ageing as a risk factor for neurodegenerative disease

Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99)

Gene Therapy Strategies to Restore ER Proteostasis in Disease

Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease

Glucocerebrosidase deficiency promotes protein aggregation through dysregulation of extracellular vesicles

Down syndrome

Nrf2 activation improves experimental rheumatoid arthritis

Modeling neurodevelopmental disorder-associated humanAGO1mutations inCaenorhabditis elegansArgonautealg-1

Exosomes

Fluorescence Spectroscopic Analysis of Lateral and Transbilayer Fluidity of Exosome Membranes

Therapeutic approaches in Parkinson's disease and related disorders

Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems

The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies

The biology , function , and biomedical applications of exosomes

KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential

Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress

Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases

Selective autophagy as a potential therapeutic target for neurodegenerative disorders

Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations

Proteome-wide analysis of chaperone-mediated autophagy targeting motifs

What lysosomes actually tell us about Parkinson’s disease?

Exosomes, an Unmasked Culprit in Neurodegenerative Diseases

Systemic gene delivery to the central nervous system using Adeno-associated virus